KHDC4: A Potential Drug Target and Biomarker (G22889)

Target Name: KHDC4

NCBI ID: G22889

KHDC4

KHDC4: A Potential Drug Target and Biomarker

Ketogenic hypoxic-iscapable protein 4 (KHDC4) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and metabolic disorders.

KHDC4 is a protein that is expressed in various tissues and cells throughout the body, including the brain, heart, liver, and muscle. It is involved in the regulation of cellular processes that are critical for maintaining cellular health and have been implicated in the development and progression of several diseases.

One of the most promising aspects of KHDC4 is its potential as a drug target. KHDC4 has been shown to play a role in the regulation of cellular processes that are involved in cancer progression, including the regulation of cell division, angiogenesis, and inflammation.

In addition, KHDC4 has also been shown to be involved in the regulation of cellular processes that are involved in neurodegenerative disorders, including the regulation of neurotransmitter synthesis and release, and the regulation of cellular stress.

Another potential application of KHDC4 is as a biomarker for the diagnosis and treatment of metabolic disorders. KHDC4 has been shown to be involved in the regulation of cellular processes that are involved in metabolism, including the regulation of glucose metabolism and the regulation of lipid metabolism.

In conclusion, KHDC4 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of KHDC4 in cellular processes and to develop effective treatments for these diseases.

Protein Name: KH Domain Containing 4, Pre-mRNA Splicing Factor

Functions: RNA-binding protein involved in pre-mRNA splicing (PubMed:19641227). Interacts with the PRP19C/Prp19 complex/NTC/Nineteen complex which is part of the spliceosome (PubMed:19641227). Involved in regulating splice site selection (PubMed:19641227). Binds preferentially RNA with A/C rich sequences and poly-C stretches (PubMed:23144703)

The "KHDC4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KHDC4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets